Post by icemandios on Jan 28, 2016 14:25:37 GMT
TransEnterix, Inc. to Present at the LEERINK Partners 5th Annual Global Healthcare Conference
TransEnterix, Inc. (NYSE MKT: TRXC) announced today that Todd M. Pope, President and Chief Executive Officer, and Joseph P. Slattery, Executive Vice President and Chief Financial Officer, will present at the LEERINK Partners 5th Annual Global Healthcare Conference at the Waldorf Astoria Hotel in New York. The presentation is scheduled to take place at 3:05 pm Eastern Time on Thursday, February 11, 2016.
To access the live audio webcast or archived recording, use the following link ir.transenterix.com/events.cfm. The replay will be available on the company’s website.
About TransEnterix
TransEnterix is a medical device company that is pioneering the use of robotics to improve minimally invasive surgery by addressing the clinical and economic challenges associated with current laparoscopic and robotic options. The company is focused on the development and commercialization of the SurgiBot™ System, a single-port, robotically enhanced laparoscopic surgical platform, and the commercialization of ALF-X®, a multi-port robotic system that brings the advantages of robotic surgery to patients while enabling surgeons with innovative technology such as haptic feedback and eye tracking camera control. The SurgiBot System is not yet available for sale in any market. The ALF-X has been granted a CE Mark but is not available for sale in the US. For more information, visit the TransEnterix website at www.transenterix.com.
TransEnterix, Inc. (NYSE MKT: TRXC) announced today that Todd M. Pope, President and Chief Executive Officer, and Joseph P. Slattery, Executive Vice President and Chief Financial Officer, will present at the LEERINK Partners 5th Annual Global Healthcare Conference at the Waldorf Astoria Hotel in New York. The presentation is scheduled to take place at 3:05 pm Eastern Time on Thursday, February 11, 2016.
To access the live audio webcast or archived recording, use the following link ir.transenterix.com/events.cfm. The replay will be available on the company’s website.
About TransEnterix
TransEnterix is a medical device company that is pioneering the use of robotics to improve minimally invasive surgery by addressing the clinical and economic challenges associated with current laparoscopic and robotic options. The company is focused on the development and commercialization of the SurgiBot™ System, a single-port, robotically enhanced laparoscopic surgical platform, and the commercialization of ALF-X®, a multi-port robotic system that brings the advantages of robotic surgery to patients while enabling surgeons with innovative technology such as haptic feedback and eye tracking camera control. The SurgiBot System is not yet available for sale in any market. The ALF-X has been granted a CE Mark but is not available for sale in the US. For more information, visit the TransEnterix website at www.transenterix.com.
